01 1ZHEJIANG JINHUA CONBA BIO-PHARM. CO., LTD.
01 1RIVAROXABAN USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-03-01
Pay. Date : 2023-12-26
DMF Number : 38897
Submission : 2023-11-29
Status : Active
Type : II
20
Zhejiang Jinhua Conba Bio-pharm Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RIVAROXABAN USP, with a corresponding US DMF Number 38897.
Remarkably, this DMF maintains an Active status since its submission on November 29, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 01, 2024, and payment made on December 26, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
